A PYMNTS Company

US/Germany: P&G buys Merck health brands for $4.2B

By  |  April 19, 2018

Procter & Gamble (P&G) has agreed to buy the consumer health business of German drugmaker Merck for €3.4billion (US$4.2 billion), as the US group struggles to ignite sales of its household brands.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The acquisition will give P&G, which owns a wealth of brand names from Pampers diapers to Gillette razors, control of vitamin makers including Seven Seas and Neurobion, which are faster-growing than P&G’s household products.

    David Taylor, chief executive of P&G, said the over-the-counter healthcare business would offer “steady, broad-based growth.”

    The deal was announced on the same day that the company unveiled another quarter of anemic sales growth and shrinking profit margins as it grapples with discounting from retailers and declining pricing power for its decades-old brands. `

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.